RNA Interference-Based Therapy for Spinocerebellar Ataxia Type 7 Retinal Degeneration
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RNA Interference-Based Therapy for Spinocerebellar Ataxia Type 7 Retinal Degeneration
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 4, Pages e95362
Publisher
Public Library of Science (PLoS)
Online
2014-04-24
DOI
10.1371/journal.pone.0095362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Broad Therapeutic Benefit After RNAi Expression Vector Delivery to Deep Cerebellar Nuclei: Implications for Spinocerebellar Ataxia Type 1 Therapy
- (2014) Megan S Keiser et al. MOLECULAR THERAPY
- Optogenetics, visual prosthesis and electrostimulation for retinal dystrophies
- (2013) Sunir J. Garg et al. CURRENT OPINION IN OPHTHALMOLOGY
- Silencing Mutant ATXN3 Expression Resolves Molecular Phenotypes in SCA3 Transgenic Mice
- (2013) Edgardo Rodríguez-Lebrón et al. MOLECULAR THERAPY
- RNAi or overexpression: Alternative therapies for Spinocerebellar Ataxia Type 1
- (2013) Megan S. Keiser et al. NEUROBIOLOGY OF DISEASE
- Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier
- (2013) Kim A Lennox et al. Molecular Therapy-Nucleic Acids
- Reduction of mutant ataxin-7 expression restores motor function and prevents cerebellar synaptic reorganization in a conditional mouse model of SCA7
- (2012) S. A. Furrer et al. HUMAN MOLECULAR GENETICS
- Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA
- (2012) Anne Louise Askou et al. JOURNAL OF GENE MEDICINE
- Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis
- (2012) H.S. McLoughlin et al. NEUROSCIENCE
- An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons
- (2011) Christina E. Khodr et al. BRAIN RESEARCH
- Insulin-like growth factor-2 antisense oligonucleotides inhibits myopia by expression blocking of retinal insulin-like growth factor-2 in guinea pig
- (2011) Ren-hong Tang et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design
- (2011) J N Martin et al. GENE THERAPY
- Optogenetic therapy for retinitis pigmentosa
- (2011) V Busskamp et al. GENE THERAPY
- Spinocerebellar Ataxia Type 7 Cerebellar Disease Requires the Coordinated Action of Mutant Ataxin-7 in Neurons and Glia, and Displays Non-Cell-Autonomous Bergmann Glia Degeneration
- (2011) S. A. Furrer et al. JOURNAL OF NEUROSCIENCE
- Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system
- (2010) Erich M Ehlert et al. BMC NEUROSCIENCE
- Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia
- (2010) Juliette J. Kahle et al. HUMAN MOLECULAR GENETICS
- Non-viral siRNA delivery into the mouse retina in vivo
- (2010) Andrey Turchinovich et al. BMC Ophthalmology
- AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins
- (2009) A Georgiadis et al. GENE THERAPY
- Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene Therapy
- (2009) Naomi Chadderton et al. MOLECULAR THERAPY
- Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
- (2009) Ryan L Boudreau et al. MOLECULAR THERAPY
- ISCEV Standard for full-field clinical electroretinography (2008 update)
- (2008) M. F. Marmor et al. DOCUMENTA OPHTHALMOLOGICA
- Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo
- (2008) Ryan L Boudreau et al. MOLECULAR THERAPY
- Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
- (2008) J. L. McBride et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now